Blog - INTERNET MÉDICA

Cardiologia do Esporte & Exercício: Diretrizes Médicas Online (Sports Cardiology & Exercise: Guidelines)

Por Paulo Leite 01/04/2019

■ Atualização da Diretriz em Cardiologia do Esporte e do Exercício da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Medicina do Exercício e Esporte 2019

N Ghorayeb, R Stein, D J Daher et al

Arq Bras Cardiol 2019, vol 112 (3)

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000300326&lng=pt&nrm=iso&tlng=pt

■ Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease

A position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)

M Borjesson, M Dellborg, J Niebauer et al

European Heart Journal 2019, vol 40 (1): 13-18

https://academic.oup.com/eurheartj/article/40/1/13/5056172

■ Recommendations for participation in competitive sports of athletes with arterial hypertension

J Niebauer, M Börjesson, F Carre et al

A position statement from the Sports Cardiology Section of the European

Association of Preventive Cardiology (EAPC)

European Heart Journal 2018, vol 39 (40): 3364-3671

3-18

https://academic.oup.com/eurheartj/article/39/40/3664/5079290

■ A new consensus document on electrocardiographic interpretation in athletes: Does it help to prevent sudden cardiac death in athletes?

M. Panhuyzen-Goedkoop, H. T. Jørstad, J. L. R. M. Smeets

Neth Heart J. , vol 26(3): 127–132

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818375/

■ International criteria for electrocardiographic interpretation in athletes: consensus statement

J A Drezner, S Sharma, A Baggish et al

British Journal of Sports Medicine 2017, vol 51 (9)

https://bjsm.bmj.com/content/51/9/704

■ Return-to-play for athletes with genetic heart diseases

K L Turkowski, J Martijn Bos, J, N C Ackerman et al

Circulation 2018, vol 137 (10)

https://www.ahajournals.org/doi/full/10.1161/circulationaha.117.031306

■ Cardiac screnning of young athletes: a practical approach to sudden cardiac death prevention

H Dhutia, H MacLachlan

Curr Treat Options Cardiovascu Med 2018, vol 20(10): 85

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132782/

■ Pre-participation screening of asymptomatic athletes

A Mosterd

Neth Heart J 2018, vol 26 (3): 123-126

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818374/

■ Eligibility and disqualification recommendation for competitive athletes with cardiovascular abnormalities: Task Force12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators

A Scientific Statement From the American Heart Association and American College of Cardiology

M S Link, R J Myerburg, N A Mark Esteslll

Circulation 2015, vol 132 (22)

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000248

■ by Dr Paulo Fernando Leite

Cardiologia

– Centro Médico Unimed BH/Pedro I/Contagem

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com

Síndrome de Maffucci Online (Maffucci Syndrome)

Por Paulo Leite 30/03/2019

¨A síndrome de Maffucci é uma displasia mesodérmica congênita rara, caracterizada pela associação de malformações venosas cutâneas com discondroplasia, que constitui uma displasia no tecido cartilaginoso. Não apresenta preferência por sexo ou raça. Síndrome de Maffucci é uma condição congênita rara, às vezes confundida com a doença de Ollier, caracterizada por encondromas múltiplos associados com hemangiomas e flebectasia. A concomitância com neoplasias primárias tem sido relatada esporadicamente. As lesões de pele surgem geralmente na infância, em torno dos quatro anos de idade, porém, em 27% dos pacientes, podem estar presentes ao nascimento. Essas lesões crescem proporcionalmente com a criança e não tendem à resolução espontânea. Linfangiomas estão freqüentemente associados e podem ser a única manifestação cutânea da doença. Outros achados cutâneos têm sido relatados e incluem alterações pigmentares, particularmente manchas café-com-leite. O trato gastrointestinal pode apresentar anomalias vasculares. Vários tumores mesodérmicos benignos e malignos têm sido relatados na síndrome de Maffucci, e a doença tem alto potencial maligno. O tumor maligno mais comum é o condrossarcoma, que pode surgir a partir dos encondromas, ocorrendo em 15% dos casos. Outras neoplasias mesodérmicas malignas podem estar associadas e incluem: fibrossarcoma, angiossarcoma, linfangiossarcoma, osteossarcoma e tumores de ovário benignos e malignos. Tumores não mesodérmicos, como gliomas e adenocarcinoma de pâncreas, também têm sido descritos. O alto potencial maligno da doença justifica a necessidade de cuidadoso seguimento dos pacientes. O tratamento cirúrgico das lesões de pele justifica-se por razões estéticas.¨

■ Maffucci syndrome associated with adrenocorticotropic hormone-independent bilateral macronodular adrenal hyperplasia

Domenico Tricò, Eliana Battaglia, Giampaolo Bernini

J Endocr Soc. 2017 Jan 1; 1(1): 51–56

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677212/

■ Sclerosing angiomatoid nodular transformation of the spleen in a patient with Maffucci syndrome: a case report and review of literature

Xiao-Dan Huang, Hao-Sen Jiao, Zheng Yang et al

Diagn Pathol. 2017; 12: 79

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681755/

■ Maffucci syndrome and neoplasms: a case report and review of the literature

O Prokopchuk, S Andres, K Becker et al

BMC Res Notes 2016, vol 9: 126

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769492/

■ Maffucci syndrome

Y Tsao, C Tsai, W Chen

The Journal of Rheumatology 2015, vol 42 (12): 2434-2435

http://www.jrheum.org/content/42/12/2434

■ Maffucci syndrome: Anaesthetic management and review of literature

G P Singh, B Bindu, M P Pandia et al

J Neuroanaesthesiol Crit Care2015, vol 2: 136-138

http://www.jnaccjournal.org/article.asp?issn=2348-0548;year=2015;volume=2;issue=2;spage=136;epage=138;aulast=Singh

■ Maffucci syndrome: enchondromas to closely monitor

Azouz M, Elyaacoubi M.

Pan Afr Med J. 2015 Apr 14;20:358

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495784/

■ Common somatic alterations identified in Maffucci syndrome by molecular karyotyping

Mustapha Amyere, Anne Dompmartin, Vinciane Wouters et al

Mol Syndromol. 2014 Dec; 5(6): 259–267.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281579/

■ Chondrosarcoma of the nasal cavity in a patient with Maffucci syndrome: case report and review of the literature

Teresa B Steinbichler, Florian Kral, Susanne Reinold, Herbert Riechelmann

World J Surg Oncol. 2014; 12: 387

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301862/

■ IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome

Kunihiko Moriya, Mika K Kaneko, Xing Liu et al

Cancer Sci. 2014 Mar; 105(3): 359–362.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317937/

■ Síndrome de Maffucci

L M Renosto, M M C de Souza, M J M Cabral, J G C Vieira Filho

Revista Brasileira de Cirurgia Plástica 2011, vol 26 (3 Supp.1)

http://www.rbcp.org.br/details/1019/sindrome-de-maffucci

■ Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: An International Multicenter Study of !61 patients

Suzan H.M. Verdegaal, Judith V.M.G. Bovée, Twinkal C. Pansuriya et al

Oncologist. 2011 Dec; 16(12): 1771–177

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248776/

■ Somatic mosaic IDH1 or IDH2 mutations are associated with nchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

Twinkal C. Pansuriya, Ronald van Eijk, Pio d’ Adamo et al

Nat Genet. 2011 Dec; 43(12): 1256–1261

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427908/

■ Maffucci syndrome with hemangioma of the liver

Raffaele Pezzilli, Carla Serra, Paola Tomassetti, et al

Case Rep Gastroenterol. 2009; 3(1): 1–4.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895167/

■ Maffucci’s syndrome complicated by intracranial chondrosarcoma: two new illustrative cases.